Journals / Acta Orthopaedica et Traumatologica Turcica / 2009 / Cilt: 43 - Sayı: 3

Major risk factors for the second contralateral hip fracture in the elderly

Yaşlılarda karşı taraf ikinci kalça kırığı için başlıca risk faktörleri

Pages
193–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We concluded that, of all the risk factors for the first hip fractures, only hypotrophic changes in the proximal femoral trabeculae, eye diseases, and neurological diseases acted as major risk factors for the second contralateral hip fractures in the elderly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The purpose of this study was to determine which of the predisposing risk factors for the first hip fracture would continue to be effective for the development of the second hip fracture in the elderly.
📊
Key Findings & Data:Methods: Data of 125 patients (31 men, 94 women) aged 55 years or older were evaluated, who sustained first (group 1, n=97) and second contralateral (group 2, n=28) hip fracture.
💡
Conclusion & Impact:Conclusion: We concluded that, of all the risk factors for the first hip fractures, only hypotrophic changes in the proximal femoral trabeculae, eye diseases, and neurological diseases acted as major risk factors for the second contralateral hip fractures in the elderly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Düşme kazaları · Kalça kırıkları · Yaş faktörü

Abstract

Objectives: The purpose of this study was to determine which of the predisposing risk factors for the &#64257;rst hip fracture would continue to be effective for the development of the second hip fracture in the elderly. Methods: Data of 125 patients (31 men, 94 women) aged 55 years or older were evaluated, who sustained &#64257;rst (group 1, n=97) and second contralateral (group 2, n=28) hip fracture. Patients who were treated with bisphosphonate, calcitonin, and estrogen were not included. Results: The incidence of the second hip fracture was higher (78.6%) beyond 12 months of the &#64257;rst fracture. The risk for sustaining a second hip fracture was 3.96-fold greater in patients over 85 years of age (p<0.05). Among comorbid medical conditions, eye diseases (p=0.02) and neurological diseases (p=0.048) were seen signi&#64257;cantly more frequent in group 2. There was an obvious relationship between the second hip fracture and lower Singh index grades of &#8804;3 (p<0.001). Patients over 85 years of age and having a lower Singh index grade were found to have a 6.57-fold increased risk for developing a second hip fracture (95% CI: 2.13-20.3; p=0.001). In univariate analysis, neurological diseases represented a signi&#64257;cantly increased risk. Eye diseases were highly associated with an increased risk for second hip fractures in univariate (OR: 3.3, 95% CI: 1.2-9.2, p=0.020) and multivariate (OR: 7.6, 95% CI: 1.9-30.7, p=0.004) analyses. The Singh index of grade &#8804;3 showed the highest associations with second hip fractures in both univariate (OR: 18.9, 95% CI: 5.8-65.9, p<0.001) and multivariate (OR: 30.00, 95% CI: 7.9-112.9, p<0.001) analyses. Conclusion: We concluded that, of all the risk factors for the &#64257;rst hip fractures, only hypotrophic changes in the proximal femoral trabeculae, eye diseases, and neurological diseases acted as major risk factors for the second contralateral hip fractures in the elderly.

Özet

Amaç: Bu çalışmada, yaşlılarda ilk kalça kırığına zemin hazırlayan risk faktörlerinden hangilerinin ikinci kalça kırığı gelişimi için de risk faktörü olmayı sürdürdüğünün belirlenmesi amaçlandı. Çalışma planı: Yaşları 55 veya daha yukarı olan, kalça kırıklı 125 hastanın (31 erkek, 94 kadın) verileri değerlendirildi. Doksan yedi hastada kalça kırığı ilk kez, 28 hastada karşı taraf kalçada ikinci kez kırık oluşmuştu. Bifosfonat, kalsitonin ve östrojen tedavisi gören hastalar çalışmaya alınmadı. Sonuçlar: İkinci kalça kırığı çoğunlukla (%78.6) ilk kırıktan 12 ay sonraki dönemde meydana gelmişti. Seksen beş yaş üzeri hastalarda ikinci kırık riski 3.96 kat artmış bulundu (p<0.05). Eşlik eden hastalıklardan, göz hastalıkları (p=0.02) ve nörolojik hastalıklar (p=0.048) ikinci kırık grubunda anlamlı derecede sıktı. İkinci kırık oluşumu ile Singh indeksi derecelerindeki düşüklük (≤3) arasında anlamlı ilişki görüldü (p<0.001). Yaşı 85’in üzerinde olan ve Singh indeksi derecesi ≤3 olan hastalarda ikinci kırık riski 6.57 kat artmış bulundu (%95 GA: 2.13-20.3; p=0.001). Tekdeğişkenli analizde, nörolojik hastalıkların riski anlamlı derecede artırdığı görüldü. Göz hastalıkları, hem tekdeğişkenli analizde (OO: 3.3, %95 GA: 1.2-9.2, p=0.020) hem de çokdeğişkenli analizde (OO: 7.6, %95 GA: 1.9-30.7, p=0.004) yüksek derecede riski temsil etmekteydi. Singh indeksi derecesinin ≤3 olması ise ikinci kırıkla en yüksek ilişki gösteren risk faktörü olarak bulundu (tekdeğişkenli analizde, OO: 18.9, %95 GA: 5.8-65.9, p<0.001; çokdeğişkenli analizde, OO: 30.00, %95 GA: 7.9-112.9, p<0.001). Çıkarımlar: Bulgularımız, yaşlılarda birinci kalça kırığına ait risk faktörleri içinden sadece üçünün (femur proksimalinde trabeküler yapıdaki hipotrofik değişimler, göz hastalıkları ve nörolojik hastalıklar) ikinci kalça kırığı için de başlıca risk faktörleri olduğunu göstermektedir.

🔖

Cite This Article

ANGTHONG, C., SUNTHARAPA, T., HARNROONGROJ, T. (2009). Major risk factors for the second contralateral hip fracture in the elderly. Acta Orthopaedica et Traumatologica Turcica, Cilt: 43 - Sayı: 3, 193–198. https://ajindex.com/articles/354621

References (15)

  1. Yamanashi A, Yamazaki K, Kanamori M, Mochizuki K, Okamoto S, Koide Y, et al. Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos Int 2005;16:1239-46
  2. Dretakis KE, Dretakis EK, Papakitsou EF, Psarakis S, Steriopoulos K. Possible predisposing factors for the second hip fracture. Calcif Tissue Int 1998;62:366-9
  3. Fukushima T, Sudo A, Uchida A. Bilateral hip fractures. J Orthop Sci 2006;11:435-8
  4. Singh M, Nagrath AR, Maini PS. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg [Am] 1970;52:457-67
  5. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991
  6. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1993;307:1248-50
  7. Anderson GH, Raymakers R, Gregg PJ. The incidence of proximal femoral fractures in an English county. J Bone Joint Surg [Br] 1993;75:441-4
  8. Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR. Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures. Osteoporos Int 2003;14:130-6
  9. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73
  10. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996;348:145-9
  11. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999;282:1344-52
  12. Schrøder HM, Petersen KK, Erlandsen M. Occurrence and incidence of the second hip fracture. Clin Orthop Relat Res 1993;(289):166-9
  13. Karachalios T, Lyritis GP, Kaloudis J, Roidis N, Katsiri M. The effects of calcitonin on acute bone loss after pertrochan- teric fractures. A prospective, randomised trial. J Bone Joint Surg [Br] 2004;86:350-8
  14. Egan M, Jaglal S, Byrne K, Wells J, Stolee P. Factors associated with a second hip fracture: a systematic review. Clin Rehabil 2008;22:272-82
  15. Pogrund H, Rigal WM, Makin M, Robin G, Menczel J, Steinberg R. Determination of osteoporosis in patients with fractured femoral neck using the Singh index: a Jerusalem study.